Spyre Therapeutics (SPY) CFO Scott Burrows Sells $2.28M in Shares
Published on · Source: investing.com
AI Summary
Summarized by AI from the source belowScott Burrows, the CFO of Spyre Therapeutics (SPY), has sold shares valued at $2.28 million. This sale adds to his previous divestitures this year, which may raise questions among investors about insider confidence in the company. The specific number of shares sold and the selling price per share were not disclosed in the announcement. Such insider sales can impact market perception and influence stock performance, making this an important development for investors to watch.
Informational only, not financial advice. Content is AI-generated and may contain errors. How this works.
Get the weekly market brief
One email every Monday: what moved, why, and what to watch. Free, unsubscribe anytime.
Get stories like this as they break
Our Telegram channel posts every market story the moment it is published. Free, and you can mute or leave anytime.
